Bafna Pharmaceuticals Limited
BAFNAPHARM.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.43B
Close$
Share Statistics
| Market cap | $2.43 Billion |
|---|---|
| Enterprise Value | $2.43 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.76 |
| Beta | -0.03 |
| Outstanding Shares | 23,698,601 |
Return
| Return on Equity | 8.10% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 127.05 |
|---|---|
| PEG | -129.93 |
| Price to Sales | 1.71 |
| Price to Book Ratio | 2.56 |
| Enterprise Value to Revenue | 1.68 |
| Enterprise Value to EBIT | 23.98 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bafna Pharmaceuticals Ltd.
339 employees
CEO: Bansilal Mahaveer Chand Bafna Bafna Pharmaceuticals Ltd. specializes in the production and distribution of finished pharmaceutical drugs within India. The company also maintains a significant international presence, exporting its medicinal products to a broad range o...